MA07.04 Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLCM.E. Marmarelis, B.C. Cho, S. Waqar et al.|Journal of Thoracic Oncology|2022Cited by 4
MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2S.-H. Lee, M.E. Marmarelis, Byoung Chul Cho et al.|Journal of Thoracic Oncology|2023Cited by 4